When to harvest peripheral-blood stem cells after mobilization therapy: Prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood

Journal of Clinical Oncology

Volumn 14, Issue 3, 1996, Pages 970-973

  Elliott, C ^a   Samson, D M ^a   Armitage, S ^a   Lyttelton, M P ^a   McGuigan, D ^a   Hargreaves, R ^a   Giles, C ^a   Abrahamson, G ^a   Abboudi, Z ^a   Brennan, M ^a   Kanfer, E J ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; GERM CELL TUMOR; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOMA; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 9044224026     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.3.970     Document Type: Article

References (12)

1. + cells in peripheral and cord blood by flow cytometry. Exp Hematol 22:1003-1010, 1994
2. Elias AD, Ayash L, Anderson KC, et al: Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79:3036-3044, 1992
3. Chao NJ, Schriber JR, Grimes K, et al: Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031-2035, 1993
4. Liberti G, Pearce R, Taghipour G, et al: Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: A case-controlled analysis of the EBMT Registry data. Ann Oncol 5:151-153, 1994 (suppl 2)
5. Bensinger WI, Longin K, Appelbaum F, et al: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825-831, 1994
6. + blood cells predicts the colony-forming capacity of leukapheresis products in children. Bone Marrow Transplant 15:25-31, 1995
7. Zimmerman TM, Lee WJ, Bender JG, et al: Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant 15:439-444, 1995
8. Pettengell R, Morgenstern GR, Woll PJ, et al: Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 82:3770-3777, 1993
9. Bender JG, To LB, Williams S, et al: Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1:329-341, 1992
10. Jones HM, Jones SA, Watts MJ, et al: Development of a simplified single-apheresis approach for peripheral-blood progenitor-cell transplantation in previously treated patients with lymphoma. J Clin Oncol 12:1693-1702, 1994
11. Passos-Coelho JL, Braine HG, Davis JM, et al: Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 13:705-714, 1995
12. Fruehauf S, Haas R, Conradt C, et al: Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (r-methuG-CSF)-supported cytotoxic chemotherapy. Blood 85:2619-2626, 1995